Brief: Immunovant Announces Pricing Of $450 Million Common Stock Financing
Sept 27 (Reuters) - Immunovant Inc IMVT.O :
* IMMUNOVANT ANNOUNCES PRICING OF $450 MILLION COMMON STOCK
FINANCING
* IMMUNOVANT OFFERED 7.4 MILLION SHARES OF ITS COMMON STOCK
IN
PUBLIC OFFERING, AT AN OFFERING PRICE OF $38.00 PER SHARE
Source text for Eikon: ID:nGNXds4kb
Further company coverage: IMVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunovant
See all newsU.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
Immunovant falls as drug for thyroid eye disease fails late-stage trials
Immunovant falls as eye disease therapy fails in late-stage studies
Immunovant Q3 net loss smaller than expected
Brief: Immunovant Q3 Net Income USD -110.635 Million Vs. IBES Estimate USD -125.1 Million